SCHEMBL86122

SCHEMBL86122

NC(CO)(CO)CCc1ccc(OCCCc2cccc(Cl)c2)c(C(F)(F)F)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 5/20 0.67
MRGPRX4 Q96LA9 4/20 0.42
TNNC1 P63316 5/20 0.38
SGPL1 O95470 1/20 0.38
S1PR4 O95977 1/20 0.38
GPR183 P32249 1/20 0.38
CERS2 Q96G23 1/20 0.38
S1PR3 Q99500 1/20 0.38
S1PR5 Q9H228 1/20 0.38
HTR2C P28335 1/20 0.38
SLC6A4 P31645 1/20 0.38
HTR2B P41595 1/20 0.38
HTR6 P50406 1/20 0.38
HTR3E A5X5Y0 1/20 0.37
HTR3B O95264 1/20 0.37
HTR3A P46098 1/20 0.37
HTR3D Q70Z44 1/20 0.37
HTR3C Q8WXA8 1/20 0.37
GRIN2B Q13224 1/20 0.36
GRM2 Q14416 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL80448 0.99 S1PR1 (0.66) S1PR1MRGPRX4TNNC1SGPL1S1PR4
SCHEMBL86356 0.91 S1PR1 (0.69) S1PR1MRGPRX4TNNC1SGPL1S1PR4
Hydrochloric Acid SCHEMBL82272 0.90 S1PR1 (0.68) S1PR1TNNC1SGPL1S1PR4GPR183
SCHEMBL86824 0.90 S1PR1 (0.71) S1PR1MRGPRX4TNNC1SGPL1S1PR4
SCHEMBL81815 0.90 S1PR1 (0.55) S1PR1MRGPRX4S1PR4S1PR3S1PR5
SCHEMBL81816 0.90 S1PR1 (0.55) S1PR1MRGPRX4S1PR4S1PR3S1PR5
Hydrochloric Acid SCHEMBL80622 0.89 S1PR1 (0.69) S1PR1MRGPRX4TNNC1SGPL1S1PR4
SCHEMBL86361 0.89 S1PR1 (0.72) S1PR1TNNC1SGPL1S1PR4GPR183
SCHEMBL86252 0.89 S1PR1 (0.55) S1PR1S1PR4S1PR3S1PR5
SCHEMBL86342 0.88 S1PR1 (0.68) S1PR1MRGPRX4TNNC1SGPL1S1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129361-B2 Amine compound and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-03-06 US disclosed
US-8129361-B2 Amine compound and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2012-03-06 US disclosed
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-15 US disclosed
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179216-A1 AMINE COMPOUND AND PHARMACEUTICAL USE THEREOF HLA-B, HLA-A, HLA-C S1PR1 511/4885MRGPRX4 92/4885TNNC1 602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.